Jasper Therapeutics, Inc.
Recent Filings
All 431 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G | — | Feb 25, 2026 |
| 4 | — | Feb 10, 2026 |
| SCHEDULE 13G/A | — | Jan 26, 2026 |
| 8-K | CURRENT REPORT | Jan 8, 2026 |
| 8-K | CURRENT REPORT | Jan 7, 2026 |
| 4 | — | Jan 5, 2026 |
| 4 | — | Jan 5, 2026 |
| 4 | — | Jan 5, 2026 |
| 8-K | CURRENT REPORT | Dec 2, 2025 |
| SCHEDULE 13G | — | Dec 2, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| WIGGANS THOMAS G | — | Purchase | 41,000 @ $2.43 | Sep 22, 2025 |
| Lucas Svetlana | — | Purchase | 20,000 @ $2.43 | Sep 22, 2025 |
| MARTELL RON | President and CEO | Purchase | 41,000 @ $2.43 | Sep 22, 2025 |
| Shizuru Judith Anne | — | Purchase | 41,000 @ $2.43 | Sep 22, 2025 |
| Mahal Jeetinder Singh | Chief Operating Officer | Sale | 900 @ $22.11 | Dec 12, 2024 |
| Tucker Edwin Jonathan | Chief Medical Officer | Award / Grant | 400 @ $4.17 | Jun 7, 2024 |
| Abingworth LLP | — | Purchase | 190,000 @ $12.95 | Feb 8, 2024 |
| VENKATARAMAN BALAJI | — | Purchase | 350,000 @ $12.95 | Feb 8, 2024 |
| WIGGANS THOMAS G | — | Purchase | 10,000 @ $0.65 | Nov 28, 2023 |
| WIGGANS THOMAS G | — | Purchase | 10,000 @ $0.64 | Nov 21, 2023 |